PRMT5 (O14744) variants and mutations
PRMT5 (also known as O14744) is a human protein-coding gene encoding a protein arginine N-methyltransferase 5 protein. It symmetrically methylates arginine residues on histones, spliceosomal proteins, and signaling factors, coordinating transcription, RNA processing, and cell growth. Many cancers depend on elevated PRMT5 activity, particularly in specific metabolic or spliceosomal contexts, making it a major therapeutic target. This analysis covers 694 PRMT5 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes neurodegenerative disease, breast cancer, and neoplasm. Example PRMT5 variants include M1?, A2V, and A3V.
Variant analysis overview
- Gene: PRMT5
- Protein: O14744
- UniProt accession: O14744
- Organism: Homo sapiens
- Variants analyzed: 694
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 501 unspecified-consequence records; 1 stop lost; 93 missense variants; 10 frameshift variants; 69 synonymous variants; 3 stop-gained variants; 7 splice-region variants; 1 in-frame deletions; 9 substitution
- Prediction scores: 549 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neurodegenerative disease, breast cancer, neoplasm, hepatocellular carcinoma, colorectal carcinoma, lung carcinoma, lung cancer, breast carcinoma, acute myeloid leukemia, cancer, pancreatic neoplasm, glioblastoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 7 binding sites; 1 post-translational modification sites.
- Structural context: 358 variants have structural context.
- PTM context: 1 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PRMT5 variants
Examples include M1?, A2V, A3V, M4I, A5T, A5V, V6A, G7A. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5354, cosmic curated COSV53545, Variant assessed as somatic; high impact.
- A2V (p.Ala2Val), ExAC rs775953236, gnomAD rs775953236, REVEL 0.12, CADD 25.40
- A3V (p.Ala3Val), cosmic curated COSV10956, TOPMed rs200812239, gnomAD rs200812239, REVEL 0.16, CADD 24.10
- M4I (p.Met4Ile), TOPMed rs1338985213, gnomAD rs1338985213, REVEL 0.10, CADD 24.80
- A5T (p.Ala5Thr), rs1259929505, NCI-TCGA Cosmic COSV5354, cosmic curated COSV53544, TOPMed rs1259929505, REVEL 0.20, CADD 25.50, Variant assessed as somatic; moderate impact.
- A5V (p.Ala5Val), ESP rs375927056, ExAC rs375927056, TOPMed rs375927056, gnomAD rs375927056, REVEL 0.15, CADD 32.00
- V6A (p.Val6Ala), Ensembl rs2044499219
- G7A (p.Gly7Ala), ExAC rs756343350, TOPMed rs756343350, gnomAD rs756343350, REVEL 0.26, CADD 21.80, Uncertain significance
- G7E (p.Gly7Glu), rs756343350, ClinGen CA388947080, ClinVar RCV004104994, ExAC rs756343350, REVEL 0.28, CADD 25.40, Uncertain significance, not specified
- G7R (p.Gly7Arg), gnomAD rs1402305196, CADD 16.30
- G7V (p.Gly7Val), cosmic curated COSV53545, ExAC rs756343350, TOPMed rs756343350, gnomAD rs756343350, CADD 18.60, Uncertain significance
- G7W (p.Gly7Trp), cosmic curated COSV10457, gnomAD rs1402305196, REVEL 0.34, CADD 29.90
- G8A (p.Gly8Ala), 1000Genomes rs201479952, ExAC rs201479952, TOPMed rs201479952, gnomAD rs201479952, REVEL 0.13, CADD 14.30
- G8D (p.Gly8Asp), 1000Genomes rs201479952, ExAC rs201479952, TOPMed rs201479952, gnomAD rs201479952, REVEL 0.13, CADD 15.90
- G8V (p.Gly8Val), 1000Genomes rs201479952, ExAC rs201479952, TOPMed rs201479952, gnomAD rs201479952, REVEL 0.09, CADD 16.90, Uncertain significance, not specified
- A9G (p.Ala9Gly), rs752005720, ClinGen CA388947071, ClinVar RCV004515305, ExAC rs752005720, REVEL 0.09, CADD 26.90, Uncertain significance, not specified
- A9V (p.Ala9Val), ExAC rs752005720, gnomAD rs752005720, REVEL 0.07, CADD 25.60, Uncertain significance
- G10A (p.Gly10Ala), gnomAD rs1464180555, REVEL 0.13, CADD 22.70
- G10S (p.Gly10Ser), ExAC rs766938287, gnomAD rs766938287, REVEL 0.04, CADD 34.00, Uncertain significance, not specified
- G11E (p.Gly11Glu), ExAC rs758730512, gnomAD rs758730512, REVEL 0.25, CADD 22.90
- G11W (p.Gly11Trp), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53545, REVEL 0.22, CADD 32.00, Variant assessed as somatic; moderate impact.
- S12G (p.Ser12Gly), Ensembl rs1594524597
- R13C (p.Arg13Cys), TOPMed rs914021170, gnomAD rs914021170, REVEL 0.66, CADD 33.00, Uncertain significance, not specified
- V14A (p.Val14Ala), ESP rs369536280, ExAC rs369536280, gnomAD rs369536280, REVEL 0.17, CADD 25.40
- V14L (p.Val14Leu), ExAC rs761329156, TOPMed rs761329156, gnomAD rs761329156, CADD 19.80
- V14M (p.Val14Met), ExAC rs761329156, TOPMed rs761329156, gnomAD rs761329156, REVEL 0.15, CADD 27.50
- R18S (p.Arg18Ser), Ensembl rs990041537
- D19N (p.Asp19Asn), TOPMed rs969813856, REVEL 0.13, CADD 25.80
- V23G (p.Val23Gly), Ensembl rs1594524517
- P24R (p.Pro24Arg), ExAC rs763450079, gnomAD rs763450079, REVEL 0.46, CADD 23.50
- E25K (p.Glu25Lys), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53547, TOPMed rs2044497276, Variant assessed as somatic; moderate impact.
- A27S (p.Ala27Ser), gnomAD rs2044497213, REVEL 0.12, CADD 21.70
- D28E (p.Asp28Glu), Ensembl rs2044497069, REVEL 0.13, CADD 19.10
- D28N (p.Asp28Asn), cosmic curated COSV10803, TOPMed rs1453575996, gnomAD rs1453575996, REVEL 0.05, CADD 23.30
- T29I (p.Thr29Ile), gnomAD rs1364736472, REVEL 0.22, CADD 23.70
- L30V (p.Leu30Val), ExAC rs760315574, TOPMed rs760315574, gnomAD rs760315574, REVEL 0.19, CADD 17.10, Uncertain significance, not specified
- G31E (p.Gly31Glu), ExAC rs775567375, gnomAD rs775567375, REVEL 0.19, CADD 22.30
- A32S (p.Ala32Ser), gnomAD rs1345690985, REVEL 0.24, CADD 23.00
- A32T (p.Ala32Thr), gnomAD rs1345690985, REVEL 0.15, CADD 23.10
- V33M (p.Val33Met), Ensembl rs1566637683
- K35R (p.Lys35Arg), ExAC rs772180370, gnomAD rs772180370, REVEL 0.09, CADD 23.10
- G37A (p.Gly37Ala), TOPMed rs1316718462
- G37G (p.Gly37Gly), gnomAD 14-22920729-G-T, CADD 12.30
- G37D (p.Gly37Asp), gnomAD 14-22920730-C-T, CADD 10.20
- G37C (p.Gly37Cys), gnomAD 14-22920731-C-A, CADD 14.40
- F38C (p.Phe38Cys), TOPMed rs2044477802
- D39H (p.Asp39His), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53546, NCI-TCGA Cosmic COSV9936, Ensembl rs2139254728, Variant assessed as somatic; moderate impact.
- D39N (p.Asp39Asn), NCI-TCGA Cosmic COSV5354, NCI-TCGA Cosmic COSV9936, cosmic curated COSV99363, REVEL 0.29, CADD 32.00, Variant assessed as somatic; moderate impact.
- M43I (p.Met43Ile), TOPMed rs2044477485
- V45E (p.Val45Glu), gnomAD 14-22920689-TCA-T, CADD 5.75
- V45V (p.Val45Val), gnomAD 14-22920690-C-A, CADD 7.23
- V45* (p.Val45Ter), gnomAD 14-22920691-AC-A, CADD 0.13
- V45L (p.Val45Leu), rs762929961, gnomAD 14-22920692-C-G, CADD 0.23
- V45M (p.Val45Met), rs762929961, gnomAD 14-22920692-C-T, CADD 0.28
- H47N (p.His47Asn), TOPMed rs2044477414
- H47H (p.His47His), rs767250027, gnomAD 14-22920720-G-A, CADD 12.30
- P48L (p.Pro48Leu), cosmic curated COSV53545, Ensembl rs1594522930, REVEL 0.44, CADD 31.00
- P48Q (p.Pro48Gln), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53545, Variant assessed as somatic; moderate impact.
- R49C (p.Arg49Cys), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53545, Variant assessed as somatic; moderate impact.
- R49K (p.Arg49Lys), rs772180370, []
- K51R (p.Lys51Arg), Ensembl rs2044477206
- K51N (p.Lys51Asn), rs1457316930, gnomAD 14-22920708-C-A, CADD 14.90
- K51E (p.Lys51Glu), gnomAD 14-22920710-T-C, CADD 15.40
- R52M (p.Arg52Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R52S (p.Arg52Ser), Ensembl rs2044477140
- E53A (p.Glu53Ala), gnomAD rs1333925168, REVEL 0.34, CADD 25.70
- F54L (p.Phe54Leu), Ensembl rs1566637003, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q56E (p.Gln56Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q56H (p.Gln56His), gnomAD rs1308506118, REVEL 0.03, CADD 22.40
- Q56Q (p.Gln56Gln), rs2044253083, gnomAD 14-22920696-C-T, CADD 9.85
- Q56R (p.Gln56Arg), gnomAD 14-22920696-CT-C, CADD 7.22
- Q56P (p.Gln56Pro), gnomAD 14-22920697-T-G, CADD 9.67
- Q56* (p.Gln56Ter), rs983856507, gnomAD 14-22920698-G-A, CADD 9.16
- Q56L (p.Gln56Leu), rs1452269481, gnomAD 14-22920718-T-A, CADD 16.10
- Q56K (p.Gln56Lys), gnomAD 14-22920719-G-T, CADD 17.60
- P58A (p.Pro58Ala), gnomAD rs1176032454, REVEL 0.26, CADD 22.70
- N61S (p.Asn61Ser), rs952520508, gnomAD 14-22920685-T-C, CADD 6.79
- R62P (p.Arg62Pro), rs2502384053, ClinGen CA388946574, ClinVar RCV004120007, REVEL 0.19, CADD 23.90, Uncertain significance, not specified
- R62W (p.Arg62Trp), ExAC rs751439994, gnomAD rs751439994, REVEL 0.31, CADD 33.00
- P63L (p.Pro63Leu), TOPMed rs1358325471, gnomAD rs1358325471, REVEL 0.06, CADD 23.20
- G64C (p.Gly64Cys), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53547, Variant assessed as somatic; moderate impact.
- G64V (p.Gly64Val), gnomAD 14-22920694-C-A, CADD 7.54
- G64W (p.Gly64Trp), rs1044451179, gnomAD 14-22920695-C-A, CADD 7.34
- G64G (p.Gly64Gly), gnomAD 14-22920699-G-T, CADD 13.90
- G64D (p.Gly64Asp), gnomAD 14-22920700-C-T, CADD 11.90
- G64S (p.Gly64Ser), gnomAD 14-22920701-C-T, CADD 14.40
- T67I (p.Thr67Ile), gnomAD rs1454266934, REVEL 0.32, CADD 28.60
- T67T (p.Thr67Thr), rs1225005673, gnomAD 14-22920705-G-T, CADD 7.67
- T67N (p.Thr67Asn), rs765814196, gnomAD 14-22920706-G-T, CADD 14.10
- R68* (p.Arg68Ter), cosmic curated COSV53544, ESP rs374788457, ExAC rs374788457, gnomAD rs374788457
- S69* (p.Ser69Ter), gnomAD 14-22920703-G-T, CADD 13.90
- S69L (p.Ser69Leu), gnomAD 14-22920703-G-A, CADD 13.90
- S69Q (p.Ser69Gln), rs1566627550, gnomAD 14-22920704-AG-A, CADD 6.98
- S69P (p.Ser69Pro), rs1206074242, gnomAD 14-22920704-A-G, CADD 14.30
- S69F (p.Ser69Phe), rs754610214, gnomAD 14-22920715-G-A, CADD 15.10
- S69Y (p.Ser69Tyr), gnomAD 14-22920715-G-T, CADD 14.80
- S69C (p.Ser69Cys), rs754610214, gnomAD 14-22920715-G-C, CADD 14.80
- S69R (p.Ser69Arg), gnomAD 14-22920723-G-T, CADD 13.20
- S69I (p.Ser69Ile), gnomAD 14-22920724-C-A, CADD 14.20
- S69N (p.Ser69Asn), rs2044255922, gnomAD 14-22920724-C-T, CADD 14.80
- S69G (p.Ser69Gly), rs752314923, gnomAD 14-22920725-T-C, CADD 7.46
- S74P (p.Ser74Pro), TOPMed rs1338803253, gnomAD rs1338803253, REVEL 0.20, CADD 23.60
- R76S (p.Arg76Ser), gnomAD rs1265440955
- D77N (p.Asp77Asn), Ensembl rs2044476149, REVEL 0.15, CADD 35.00
- W78C (p.Trp78Cys), Ensembl rs2044469166
- T80M (p.Thr80Met), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53547, TOPMed rs2044469095, REVEL 0.31, CADD 28.80, Variant assessed as somatic; moderate impact.
- V83A (p.Val83Ala), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53545, Variant assessed as somatic; moderate impact.
- G84A (p.Gly84Ala), ExAC rs779549081, gnomAD rs779549081, REVEL 0.32, CADD 22.60
- G84V (p.Gly84Val), ExAC rs779549081, gnomAD rs779549081, REVEL 0.64, CADD 29.00
- L86F (p.Leu86Phe), gnomAD rs1365574312, REVEL 0.23, CADD 22.60
- S87Y (p.Ser87Tyr), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53544, Variant assessed as somatic; moderate impact.
- P88A (p.Pro88Ala), ExAC rs757859083, TOPMed rs757859083, gnomAD rs757859083
- P88S (p.Pro88Ser), cosmic curated COSV10508, ExAC rs757859083, TOPMed rs757859083, gnomAD rs757859083, REVEL 0.12, CADD 21.10
- P88T (p.Pro88Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R91C (p.Arg91Cys), ExAC rs765221574, gnomAD rs765221574, REVEL 0.14, CADD 26.20
- R91H (p.Arg91His), rs757013591, NCI-TCGA Cosmic COSV5354, cosmic curated COSV53545, ExAC rs757013591, REVEL 0.02, CADD 21.50, Variant assessed as somatic; moderate impact.
- D93A (p.Asp93Ala), ExAC rs753685975, gnomAD rs753685975, REVEL 0.62, CADD 28.80
- D93E (p.Asp93Glu), TOPMed rs1271437549, gnomAD rs1271437549, REVEL 0.29, CADD 23.80
- D93N (p.Asp93Asn), NCI-TCGA Cosmic COSV9936, Variant assessed as somatic; moderate impact.
- V96A (p.Val96Ala), TOPMed rs201289389, gnomAD rs201289389, REVEL 0.09, CADD 22.30
- V96L (p.Val96Leu), ExAC rs763819555, gnomAD rs763819555, REVEL 0.04, CADD 18.10
- E97D (p.Glu97Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K98M (p.Lys98Met), gnomAD rs1193649482, REVEL 0.05, CADD 22.50
- I99T (p.Ile99Thr), rs759768927, ClinGen CA7107398, ClinVar RCV004515306, ExAC rs759768927, REVEL 0.09, CADD 22.80, Uncertain significance, not specified
- R100C (p.Arg100Cys), rs774444973, NCI-TCGA Cosmic COSV5354, cosmic curated COSV53546, ExAC rs774444973, REVEL 0.46, CADD 26.30, Variant assessed as somatic; moderate impact.
- R100G (p.Arg100Gly), ExAC rs774444973, TOPMed rs774444973, gnomAD rs774444973, REVEL 0.85, CADD 25.40
- R100H (p.Arg100His), rs766424540, NCI-TCGA Cosmic COSV9936, cosmic curated COSV99362, ExAC rs766424540, REVEL 0.80, CADD 29.50, Variant assessed as somatic; moderate impact.
- R100L (p.Arg100Leu), ExAC rs766424540, gnomAD rs766424540
- E104K (p.Glu104Lys), gnomAD rs1271702337, REVEL 0.33, CADD 25.00
- E104A (p.Glu104Ala), rs771754057, []
- A105V (p.Ala105Val), ExAC rs199877231, TOPMed rs199877231, gnomAD rs199877231, REVEL 0.11, CADD 23.40
- A106S (p.Ala106Ser), Ensembl rs867783646
- M107V (p.Met107Val), TOPMed rs888016418, gnomAD rs888016418, REVEL 0.14, CADD 22.70
- Q109E (p.Gln109Glu), Ensembl rs2139248651
- E110K (p.Glu110Lys), TOPMed rs1433171038, gnomAD rs1433171038, REVEL 0.59, CADD 27.40
- E110Q (p.Glu110Gln), TOPMed rs1433171038, gnomAD rs1433171038, REVEL 0.43, CADD 25.70
- G114V (p.Gly114Val), rs2502376480, ClinGen CA388946152, ClinVar RCV004114738, Uncertain significance, not specified
- A115T (p.Ala115Thr), gnomAD rs1188199418, REVEL 0.17, CADD 23.00
- P120S (p.Pro120Ser), ESP rs373616180, ExAC rs373616180, TOPMed rs373616180, gnomAD rs373616180, REVEL 0.29, CADD 22.70
- P120T (p.Pro120Thr), ESP rs373616180, ExAC rs373616180, TOPMed rs373616180, gnomAD rs373616180, REVEL 0.38, CADD 22.80
- A121T (p.Ala121Thr), NCI-TCGA Cosmic COSV9936, cosmic curated COSV99363, Variant assessed as somatic; moderate impact.
- F122L (p.Phe122Leu), NCI-TCGA TCGA novel, REVEL 0.19, CADD 22.60, Variant assessed as somatic; moderate impact.
- L126F (p.Leu126Phe), ESP rs368112038, ExAC rs368112038, TOPMed rs368112038, gnomAD rs368112038, REVEL 0.25, CADD 23.40
- L126V (p.Leu126Val), ESP rs368112038, ExAC rs368112038, TOPMed rs368112038, gnomAD rs368112038, REVEL 0.21, CADD 19.80
- N127H (p.Asn127His), gnomAD rs1470908143
- N127K (p.Asn127Lys), 1000Genomes rs545739459, ExAC rs545739459, gnomAD rs545739459, REVEL 0.10, CADD 17.20
- N127T (p.Asn127Thr), Ensembl rs1566636055
- Q128R (p.Gln128Arg), ExAC rs765437315, gnomAD rs765437315, REVEL 0.03, CADD 20.60
- E129G (p.Glu129Gly), TOPMed rs1459704486, gnomAD rs1459704486, REVEL 0.10, CADD 22.90
- T132I (p.Thr132Ile), Ensembl rs1594520988, REVEL 0.15, CADD 21.80
- T132P (p.Thr132Pro), Ensembl rs1594520994
- N133S (p.Asn133Ser), ExAC rs762341644, REVEL 0.27, CADD 25.30
- N133T (p.Asn133Thr), ExAC rs762341644
- L138F (p.Leu138Phe), NCI-TCGA TCGA novel, REVEL 0.20, CADD 24.90, Variant assessed as somatic; moderate impact.
- T139P (p.Thr139Pro), Ensembl rs1594520952, REVEL 0.16, CADD 22.70
- T139S (p.Thr139Ser), TOPMed rs1313292314, gnomAD rs1313292314, REVEL 0.25, CADD 19.50
- N140K (p.Asn140Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N140S (p.Asn140Ser), TOPMed rs1284224827, gnomAD rs1284224827, REVEL 0.05, CADD 21.30
- T144I (p.Thr144Ile), TOPMed rs1237618888, REVEL 0.15, CADD 22.50
- T144N (p.Thr144Asn), TOPMed rs1237618888
- H147Y (p.His147Tyr), rs201524125, ClinGen CA7107362, ClinVar RCV004286297, ExAC rs201524125, REVEL 0.33, CADD 21.50, Uncertain significance, not specified
- S148F (p.Ser148Phe), NCI-TCGA Cosmic COSV5354, cosmic curated COSV53546, Variant assessed as somatic; moderate impact.
- M150T (p.Met150Thr), ExAC rs770437054, TOPMed rs770437054, gnomAD rs770437054, REVEL 0.44, CADD 22.50
- M150V (p.Met150Val), ExAC rs778358225, gnomAD rs778358225, REVEL 0.17, CADD 22.80
- F151=, NCI-TCGA TCGA novel, Variant assessed as somatic; low impact.
- M153I (p.Met153Ile), NCI-TCGA Cosmic COSV9936, cosmic curated COSV99363, Variant assessed as somatic; moderate impact.
- M153T (p.Met153Thr), ExAC rs767903559, gnomAD rs767903559, REVEL 0.13, CADD 23.70
- M153V (p.Met153Val), TOPMed rs2044430964, REVEL 0.06, CADD 22.60
- R154Q (p.Arg154Gln), TOPMed rs753096989, REVEL 0.06, CADD 23.50
- R154W (p.Arg154Trp), rs373936905, cosmic curated COSV10457, ESP rs373936905, ExAC rs373936905, REVEL 0.30, CADD 29.90, Variant assessed as somatic; moderate impact.
- P156H (p.Pro156His), ExAC rs774009994, gnomAD rs774009994, REVEL 0.82, CADD 29.20
- L157F (p.Leu157Phe), TOPMed rs113488776, gnomAD rs113488776, REVEL 0.36, CADD 23.50
- V158G (p.Val158Gly), gnomAD rs2044430393, REVEL 0.18, CADD 23.50
- V158L (p.Val158Leu), TOPMed rs1301983404, gnomAD rs1301983404, REVEL 0.07, CADD 19.10
- V158M (p.Val158Met), TOPMed rs1301983404, gnomAD rs1301983404
- E161D (p.Glu161Asp), ExAC rs201206132, gnomAD rs201206132, REVEL 0.22, CADD 13.90
- D162G (p.Asp162Gly), NCI-TCGA Cosmic COSV9936, cosmic curated COSV99362, Variant assessed as somatic; moderate impact.
- D162Y (p.Asp162Tyr), ExAC rs765726296, TOPMed rs765726296, gnomAD rs765726296, REVEL 0.25, CADD 24.90
- L163P (p.Leu163Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R164K (p.Arg164Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public PRMT5 analysis runs
- PRMT5 analysis run — PRMT5 (694 variants) — completed 2026-08-19